Herpes simplex encephalitis. Is anticoagulation safe?
Publication/Presentation Date
5-1-2005
Abstract
BACKGROUND: Herpes simplex encephalitis (HSE) still carries a high morbidity and mortality.
REVIEW SUMMARY: The authors report a 27-year-old patient who presented with an HSE manifested by a high temperature, seizures, and headaches. His hospitalization course was complicated by a pulmonary embolism. After anticoagulation was started, the patient developed a right temporal hematoma at the same region of the abnormal signal on magnetic resonance imaging. The patient underwent a craniotomy and evacuation of the hematoma with an uneventful postoperative outcome.
CONCLUSION: The safety of anticoagulation in HSE has not been raised in the literature previously, and it needs further study.
Volume
11
Issue
3
First Page
187
Last Page
189
ISSN
1074-7931
Published In/Presented At
Jabbour, P. M., & Ojemann, S. G. (2005). Herpes simplex encephalitis. Is anticoagulation safe?. The neurologist, 11(3), 187–189. https://doi.org/10.1097/01.nrl.0000159761.57148.70
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
15860143
Department(s)
Administration and Leadership
Document Type
Article